Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1972-4-4
|
pubmed:language |
spa
|
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:author | |
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1-25
|
pubmed:dateRevised |
2009-11-11
|
pubmed:meshHeading |
pubmed-meshheading:5406970-Administration, Oral,
pubmed-meshheading:5406970-Benzyl Compounds,
pubmed-meshheading:5406970-Carboxy-Lyases,
pubmed-meshheading:5406970-Dihydroxyphenylalanine,
pubmed-meshheading:5406970-Dopamine,
pubmed-meshheading:5406970-Humans,
pubmed-meshheading:5406970-Hydrazines,
pubmed-meshheading:5406970-Parkinson Disease
|
pubmed:articleTitle |
[Therapy of Parkinson's syndrome with L-dopa per os combined with a decarboxylase inhibitor (Ro 46.02)].
|
pubmed:publicationType |
Journal Article
|